| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
18,540,000 |
| Market
Cap: |
272.35(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.39 - $33.01 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Co.'s proprietary platform technology, BAROSTIM®, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System (ANS) which causes heart failure (HF) and other cardiovascular diseases. Co.'s second-generation product, BAROSTIM NEO®, is the first and only commercially available neuromodulation device indicated to improve symptoms for patients with HF and resistant hypertension.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
78,953 |
| Total Buy Value |
$0 |
$0 |
$0 |
$437,064 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
6 |
| Total Shares Sold |
6,270 |
6,270 |
8,020 |
12,620 |
| Total Sell Value |
$151,890 |
$151,890 |
$183,171 |
$238,102 |
| Total People Sold |
2 |
2 |
2 |
2 |
| Total Sell Transactions |
2 |
2 |
4 |
5 |
| End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jain Mudit K. |
Director |
– • – |
2021-08-12 |
4 |
B |
$19.72 |
$12,328 |
D/D |
625 |
1,625 |
2.39 |
-44% |
|
| New Enterprise Associates 10 L P |
10% Owner |
– – • |
2021-07-02 |
4 |
B |
$18.00 |
$4,059,000 |
D/D |
225,500 |
2,026,083 |
2.45 |
-27% |
|
| New Enterprise Associates 10 L P |
10% Owner |
– – • |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800,583 |
1,800,583 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2021-07-02 |
4 |
B |
$18.00 |
$4,504,500 |
I/I |
250,250 |
173,388 |
1.5 |
-27% |
|
| Sandell Scott D |
10% Owner |
– – • |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,947,837 |
148,638 |
|
- |
|
| Glaxosmithkline Plc |
10% Owner |
– – • |
2021-07-02 |
4 |
B |
$18.00 |
$4,950,000 |
I/I |
275,000 |
1,007,583 |
1.5 |
-27% |
|
| Glaxosmithkline Plc |
10% Owner |
– – • |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
700,772 |
732,583 |
|
- |
|
| Johnson & Johnson Development Corp Et Al |
10% Owner |
– – • |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,495,575 |
3,495,575 |
|
- |
|
| Slattery Joseph P |
Director |
– • – |
2021-07-02 |
4 |
A |
$18.00 |
$99,990 |
D/D |
5,555 |
5,555 |
|
- |
|
| Nehra John M |
Director |
– • – |
2021-07-02 |
4 |
B |
$18.00 |
$499,986 |
D/D |
27,777 |
28,266 |
2.39 |
-27% |
|
| Jain Mudit K. |
Director |
– • – |
2021-07-02 |
4 |
B |
$18.00 |
$3,999,996 |
I/I |
222,222 |
933,383 |
2.1 |
-27% |
|
| Jain Mudit K. |
Director |
– • – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
711,161 |
711,161 |
|
- |
|
| Brintnall John |
Chief Strategy Officer and Sec |
• – – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,900 |
7,900 |
|
- |
|
| Nielsen Kirk G. |
Director |
– • – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,461,831 |
1,461,831 |
|
- |
|
| Pardo Geoffrey B |
Director |
– • – |
2021-07-02 |
4 |
B |
$18.00 |
$4,950,000 |
I/I |
275,000 |
1,829,022 |
2.1 |
-27% |
|
| Pardo Geoffrey B |
Director |
– • – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,554,022 |
1,554,022 |
|
- |
|
| Nehra John M |
Director |
– • – |
2021-07-01 |
4 |
B |
$25.80 |
$1,290 |
I/I |
50 |
100 |
2.02 |
-29% |
|
| Jain Mudit K. |
Director |
– • – |
2021-07-01 |
4 |
B |
$25.10 |
$25,100 |
D/D |
1,000 |
1,000 |
2.39 |
-29% |
|
| Nehra John M |
Director |
– • – |
2021-06-30 |
4 |
B |
$27.43 |
$1,371 |
I/I |
50 |
50 |
2.02 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.21 (1.41%) 
